GSK recalling nearly 600,000 Ventolin inhalers in U.S. http://www.fiercepharma.com/manufacturing/gsk-recalling-nearly-600-000-ventolin-inhalers-u-s With sales of its respiratory drugs doing well, GlaxoSmithKline has been spending hundreds of millions of dollars to expand manufacturing of several kinds of inhalers. But a glitch at one of its Ventolin inhaler plants has resulted in recalling nearly 600,000 units in the U.S. According to an FDA Enforcement […]
Filed under: General Problems | Leave a Comment »